Organon (OGN) Stock Price, Quote, News & History | Benzinga

Comments

Organon & Co (OGN) Stock Price, Quote, News & History

OGNNYSE

Trade with Public

Trade with Public

$7.48

0.202.75%

Last update: Feb 18, 1:34 PM

Dividend: The dividend Ex-Date is in 5 days

Earnings: Q4 2025 Earnings were released on Thu Feb 12th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 6 days ago

Click to view the webcast

OverviewNews Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$7.34

Close

-

Volume / Avg.

1.46M / 5.41M

Day Range

$7.25 - $7.49

52 Wk Range

6.18 - 16.50

Market Cap

$1.94B

P/E Ratio

10.11

Dividend Yield

1.10%

Exchange

NYSE

RSI

41

Short Interest

7.38%

Days to Cover

2.02

Recent Organon & Co News

Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report

Sun Pharma is evaluating a potential $10 billion acquisition of Organon, a move that could become India's largest cross-border pharma deal.

Vandana Singh

Organon Analysts Cut Their Forecasts Following Q3 Results

Avi Kapoor

Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday?

Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government shutdown may soon conclude.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

949.00M

Investing Cash Flow (TTM)

-621.00M

Financing Cash Flow (TTM)

-456.00M

Free Cash Flow (TTM)

566.00M

Capital Expenditure (TTM)

-383.00M

Net Change in Cash (TTM)

-128.00M

Analyst Trends and Forecast

1

1

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$10.05B

PE Ratio (TTM)

10.11

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.31

PB Ratio (TTM)

2.09

Earnings Yield % (TTM)

9.89%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

10.82

Price / EBITDA (TTM)

2.04

Price / Free Cash Flow (TTM)

3.35

Book Value / Share

$3.48

Company Debt

Total Debt

$8.83B

LT Debt

$8.78B

LT Debt Issuance (TTM)

$880.00M

LT Debt Repayment (TTM)

-$1.16B

Total Cash

$672.00M

Debt to Equity

9.74

Issuance of Debt (TTM)

-$278.00M

Repayment of Debt (TTM)

-$1.16B

Key Statistics

Open

$7.34

Close

-

Volume / Avg.

1.46M / 5.41M

Day Range

$7.25 - $7.49

52 Wk Range

6.18 - 16.50

Market Cap

$1.94B

P/E Ratio

10.11

Dividend Yield

1.10%

Exchange

NYSE

RSI

41

Short Interest

7.38%

Days to Cover

2.02

About

Sector

Health Care

Industry

Pharmaceuticals

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the followin...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Organon (OGN) stock?

A

You can purchase shares of Organon (NYSE:OGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Organon (OGN) competitors?

A

Other companies in Organon’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC) and Rapport Therapeutics Inc (NASDAQ:RAPP).

Q

What is the forecast, or price target, for Organon (OGN) stock?

A

Organon has a consensus price target of $17.64.

Q

What is the current price for Organon (OGN)?

A

The stock price for Organon (NYSE: OGN) is $7.48 last updated February 18, 2026 at 1:34 PM EST.

Q

Does Organon (OGN) pay a dividend?

A

There are no upcoming dividends for Organon.

Q

When is Organon (NYSE:OGN) reporting earnings?

A

Organon does not have any upcoming earnings scheduled.

Q

Is Organon (OGN) going to split?

A

There is no upcoming split for Organon.

Q

What sector and industry does Organon (OGN) operate in?

A

Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch

Supernus Pharmaceuticals Inc

WAVE Life Sciences Ltd

Tarsus Pharmaceuticals Inc

Phibro Animal Health Corp

Rapport Therapeutics Inc

ANI Pharmaceuticals Inc

Ocular Therapeutix Inc